ImmunoChemistry Technologies - FLIVO's Unit Acquisition

ImmunoChemistry Technologies - FLIVO raised a round of funding on October 22, 2014. Investors include The SEED Partners.

ImmunoChemistry Technologies provides quality research reagents and laboratory services to the global biomedical research community and biotechnology industries. The company's offerings focus on prote…

Articles about ImmunoChemistry Technologies - FLIVO's Unit Acquisition: